Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc., as indicated in the metadata request) on October 2, 2018. The report announces the consolidated financial results for the first quarter of fiscal year 2019. The registrant is incorporated in Delaware and maintains its principal executive offices in Santa Clara, California.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification that a press release containing these results (Exhibit 99.1) has been issued, but the financial data itself is not embedded in the body of this 8-K text.
Material Changes
No material changes or comparative financial data versus the prior period are detailed in this filing text. The report references the issuance of a press release regarding Q1 FY2019 results but does not summarize the variances or trends within the text provided.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It strictly references the attached press release (Exhibit 99.1) for the financial results. The document includes a standard disclaimer stating that the information furnished is not deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the correct registrant name: The filing is for Landec Corporation, not Lifecore Biomedical, Inc.
- Locate and review Exhibit 99.1 (the press release dated October 2, 2018) to obtain actual revenue, earnings, and cash flow figures.
- Confirm the fiscal year definition for Landec Corporation to ensure the "first quarter of fiscal year 2019" aligns with the calendar period expected.
- Note that this 8-K text does not contain audited financial statements or detailed operational metrics.